Salem Investment Counselors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,275
| Closed | -$135K | – | 704 |
|
|
2019
Q1 | $135K | Buy |
+6,275
| New | +$135K | 0.01% | 219 |
|
|
2018
Q4 | – | Sell |
-6,275
| Closed | -$135K | – | 367 |
|
|
2018
Q3 | $135K | Buy |
6,275
+800
| +15% | +$17.2K | 0.01% | 219 |
|
|
2018
Q2 | $133K | Sell |
5,475
-2,000
| -27% | -$48.6K | 0.01% | 218 |
|
|
2018
Q1 | $123K | Sell |
7,475
-500
| -6% | -$8.23K | 0.01% | 217 |
|
|
2017
Q4 | $151K | Sell |
7,975
-725
| -8% | -$13.7K | 0.02% | 211 |
|
|
2017
Q3 | $161K | Sell |
8,700
-700
| -7% | -$13K | 0.02% | 206 |
|
|
2017
Q2 | $312K | Buy |
9,400
+1,068
| +13% | +$35.4K | 0.04% | 188 |
|
|
2017
Q1 | $267K | Buy |
8,332
+32
| +0.4% | +$1.03K | 0.03% | 221 |
|
|
2016
Q4 | $301K | Buy |
8,300
+1,675
| +25% | +$60.7K | 0.03% | 215 |
|
|
2016
Q3 | $3.05K | Buy |
6,625
+575
| +10% | +$265 | 0.04% | 188 |
|
|
2016
Q2 | $304K | Buy |
+6,050
| New | +$304K | 0.04% | 218 |
|
|
2016
Q1 | – | Sell |
-3,263
| Closed | -$214K | – | 262 |
|
|
2015
Q4 | $214K | Buy |
+3,263
| New | +$214K | 0.03% | 237 |
|
|
2015
Q3 | – | Sell |
-3,489
| Closed | -$206K | – | 270 |
|
|
2015
Q2 | $206K | Buy |
3,489
+63
| +2% | +$3.72K | 0.03% | 259 |
|
|
2015
Q1 | $213K | Buy |
+3,426
| New | +$213K | 0.03% | 258 |
|
|
2014
Q3 | – | Sell |
-54,782
| Closed | -$2.87M | – | 295 |
|
|
2014
Q2 | $2.87M | Sell |
54,782
-125
| -0.2% | -$6.55K | 0.35% | 79 |
|
|
2014
Q1 | $2.9M | Buy |
54,907
+1,933
| +4% | +$102K | 0.36% | 75 |
|
|
2013
Q4 | $2.12M | Sell |
52,974
-4,550
| -8% | -$182K | 0.28% | 90 |
|
|
2013
Q3 | $2.17M | Sell |
57,524
-40,304
| -41% | -$1.52M | 0.3% | 82 |
|
|
2013
Q2 | $3.84M | Buy |
+97,828
| New | +$3.84M | 0.55% | 56 |
|